Experts say a new bivalent vaccine targeting both the original 2020 strain of COVID-19 and the Omicron variant could be a game-changer. And Australia could be on its way to acquiring the vaccine. Moderna has received permission from the Therapeutic Goods Administration [[TGA]] to apply for provisional approval for its bivalent vaccine to be used in Australia.
Share





